WallStreetZen

NASDAQ: NEO
Neogenomics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NEO

Based on 7 analysts offering 12 month price targets for Neogenomics Inc.
Min Forecast
$46.00-1.84%
Avg Forecast
$59.00+25.91%
Max Forecast
$65.00+38.71%

Should I buy or sell NEO stock?

Based on 8 analysts offering ratings for Neogenomics Inc.
Strong Buy
Strong Buy
4 analysts 50%
Buy
3 analysts 37.5%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

NEO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
Morgan Stanley
Strong BuyMaintains$58.00+23.77%2021-08-09
Goldman Sachs
Bottom 6%
6
Strong BuyInitiates Coverage On$55.00+17.37%2021-06-03
Morgan Stanley
Top 22%
79
Strong BuyMaintains$64.00+36.58%2021-02-25
Needham
Top 7%
94
BuyAssumes$65.00+38.71%2021-02-25
Raymond James
Top 22%
79
HoldDowngradesN/AN/A2021-02-25
Truist Securities
Top 3%
98
Strong BuyInitiates Coverage On$65.00+38.71%2021-01-28
SVB Leerink
Top 6%
95
BuyMaintains$60.00+28.04%2021-01-08
Needham
Top 3%
98
BuyMaintains$46.00-1.84%2020-10-28

1 of 1

Forecast return on equity

Is NEO forecast to generate an efficient return?
Company
-2.57%
Industry
43.45%
Market
1,975.18%
NEO's Return on Equity is forecast to be low in 3 years (-2.57%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is NEO forecast to generate an efficient return on assets?
Company
-1.55%
Industry
11%
Market
951.37%
NEO is forecast to generate lower Return on Assets (-1.55%) than the US Diagnostics & Research industry average (11%)
Forecast

NEO earnings per share forecast

What is NEO's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$0.34-155.74%
Avg 2 year Forecast
-$0.30-149.18%
Avg 3 year Forecast
-$0.24-139.34%

NEO revenue forecast

What is NEO's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$500.0M+2.31%
Avg 2 year Forecast
$582.1M+19.11%
Avg 3 year Forecast
$672.1M+37.52%
NEO's revenue is forecast to grow at a rate of 9.35% per year, which is not exceptional
Forecast

NEO revenue growth forecast

How is NEO forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
9.35%
Industry
6.76%
Market
14.66%
NEO's revenues are forecast to grow faster (9.35% per year) than the US Diagnostics & Research industry average (6.76%)
Forecast
NEO's revenues are forecast to grow slower (9.35% per year) than the US market average (14.66%)
Forecast

Neogenomics Stock Forecast FAQ

Is Neogenomics Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: NEO) stock is to Strong Buy NEO stock.

Out of 8 analysts, 4 (50%) are recommending NEO as a Strong Buy, 3 (37.5%) are recommending NEO as a Buy, 1 (12.5%) are recommending NEO as a Hold, 0 (0%) are recommending NEO as a Sell, and 0 (0%) are recommending NEO as a Strong Sell.

What is NEO's earnings growth forecast for 2021-2023?

(NASDAQ: NEO) Neogenomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 22.98%.

Neogenomics's earnings in 2021 is $71,733,000.On average, 4 Wall Street analysts forecast NEO's earnings for 2021 to be $-41,757,547, with the lowest NEO earnings forecast at $-46,670,199, and the highest NEO earnings forecast at $-31,932,242. On average, 4 Wall Street analysts forecast NEO's earnings for 2022 to be $-36,844,894, with the lowest NEO earnings forecast at $-52,811,015, and the highest NEO earnings forecast at $-23,335,100.

In 2023, NEO is forecast to generate $-29,475,915 in earnings, with the lowest earnings forecast at $-29,475,915 and the highest earnings forecast at $-29,475,915.

What is NEO's revenue growth forecast for 2021-2023?

(NASDAQ: NEO) Neogenomics's forecast annual revenue growth rate of 9.35% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.66%.

Neogenomics's revenue in 2021 is $488,698,000.On average, 4 Wall Street analysts forecast NEO's revenue for 2021 to be $61,408,279,816, with the lowest NEO revenue forecast at $61,165,717,596, and the highest NEO revenue forecast at $61,734,848,395. On average, 4 Wall Street analysts forecast NEO's revenue for 2022 to be $71,491,744,828, with the lowest NEO revenue forecast at $69,914,414,908, and the highest NEO revenue forecast at $72,968,856,637.

In 2023, NEO is forecast to generate $82,539,809,171 in revenue, with the lowest revenue forecast at $82,122,110,887 and the highest revenue forecast at $82,957,507,454.

What is NEO's forecast return on assets (ROA) for 2021-2023?

(NASDAQ: NEO) forecast ROA is -1.55%, which is lower than the forecast US Diagnostics & Research industry average of 11%.

What is NEO's Price Target?

According to 7 Wall Street analysts that have issued a 1 year NEO price target, the average NEO price target is $59.00, with the highest NEO stock price forecast at $65.00 and the lowest NEO stock price forecast at $46.00.

On average, Wall Street analysts predict that Neogenomics's share price could stay at $59.00 by Aug 9, 2022. The average Neogenomics stock price prediction forecasts a potential downside of N/A from the current NEO share price of $46.86.

What is NEO's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: NEO) Neogenomics's current Earnings Per Share (EPS) is $0.61. On average, analysts forecast that NEO's EPS will be $-0.34 for 2021, with the lowest EPS forecast at $-0.38, and the highest EPS forecast at $-0.26. On average, analysts forecast that NEO's EPS will be $-0.30 for 2022, with the lowest EPS forecast at $-0.43, and the highest EPS forecast at $-0.19. In 2023, NEO's EPS is forecast to hit $-0.24 (min: $-0.24, max: $-0.24).

What is NEO's forecast return on equity (ROE) for 2021-2023?

(NASDAQ: NEO) forecast ROE is -2.57%, which is considered weak.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.